Gedocarnil

This classification denotes an anxiolytic with the molecular formula C23H21ClN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BWP53NPW3F, chemically known as isopropyl 5-(p-chlorophenoxy)-4-(methoxymethyl)-9h-pyrido(3,4-b)indole-3-carboxylate. but generally known as gedocarnil, which bears US NIH Compound Identifier 219095. European Medicines Agency schedules Gedocarnil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07888MIG. The term GEDOCARNIL is an International Non-Proprietary Name. World Health Organization schedules gedocarnil in its Anatomical Therapeutic Chemical (ATC) Classification. GEDOCARNIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gedocarnil under HS 29339990 and SITC 51577. As of Q4 2014, GEDOCARNIL remains the US FDA Preferred Term for this commodity. Gedocarnil bears US NLM identifiers UMLS ID C2348738 and NCI Concept Code C74183. SMILES: CLC1CCC(OC2C3C4C([NH]C3CCC2)CNC(C4COC)C(=O)OC(C)C)CC1.